Polivy and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Polivy (polatuzumab vedotin-piiq), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Rituxan, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Rashes when taking Polivy. It is created by eHealthMe based on reports of 2,455 people who have side effects when taking Polivy from the FDA, and is updated regularly.

What is Polivy?

Polivy has active ingredients of polatuzumab vedotin-piiq. eHealthMe is studying from 2,455 Polivy users. Check the latest studies of Polivy.

What is Rashes?

Rashes (redness) is found to be associated with 3,714 drugs and 6,213 conditions by eHealthMe. Check the latest studies of Rashes.

On Jul, 14, 2026

2,455 people reported to have side effects when taking Polivy.
Among them, 33 people (1.34%) have Rashes.

Among these 33 people:

How long have people been on Polivy when they have Rashes? *

What is the gender of people who have Rashes when taking Polivy? *

female: 28.57 %
male: 71.43 %

What is the age of people who have Rashes when taking Polivy? *

What are other drugs people take besides Polivy? *

Rituxan: 12 people, 36.36%
Bendamustine Hydrochloride: 11 people, 33.33%
Cyclophosphamide: 9 people, 27.27%
Bendamustine: 5 people, 15.15%
Prednisone: 4 people, 12.12%
Prednisolone: 4 people, 12.12%
Doxorubicin Hydrochloride: 3 people, 9.09%
Lenalidomide: 3 people, 9.09%
Oxaliplatin: 3 people, 9.09%
Dexamethasone: 3 people, 9.09%

What are other side effects people have besides Rashes? *

Fever: 6 people, 18.18%
Thrombocytopenia (decrease of platelets in blood): 6 people, 18.18%
White Blood Cell Count Decreased: 4 people, 12.12%
Renal Impairment (severely reduced kidney function): 4 people, 12.12%
Anaemia (lack of blood): 4 people, 12.12%
Disease Progression: 4 people, 12.12%
Infusion Related Reaction: 4 people, 12.12%
Malignant Neoplasm Progression (cancer tumour came back): 4 people, 12.12%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 12.12%
Chest Pain: 3 people, 9.09%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 24 people, 72.73%
Diffuse Large B-Cell Lymphoma Recurrent (recurrent cancer of b cells, a type of white blood cell): 4 people, 12.12%
Diffuse Large B-Cell Lymphoma Refractory (cancer of b cells, a type of white blood cell-relapsed): 3 people, 9.09%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 3.03%
Leukaemia (blood or bone marrow cancer): 1 person, 3.03%
Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 1 person, 3.03%
Burkitt Lymphoma (cancer of the lymphatic system): 1 person, 3.03%
B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Polivy and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Polivy:

Polivy (2,455 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Polivy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,714 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,213 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on polatuzumab vedotin-piiq (the active ingredients of Polivy) and Polivy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.